![Matthew Davis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Davis
Corporate Officer/Principal bei
AQUESTIVE THERAPEUTICS, INC.
Vermögen: 402 000 $ am 31.05.2026
Profil
Matthew W.
Davis is currently an Adjunct Associate Professor at Temple University (Pennsylvania) since 2012.
He is the Chief Operating & Medical Officer at Tiziana Life Sciences Ltd. (United Kingdom) starting in 2022.
He will be the Chief Development Officer at Aquestive Therapeutics, Inc. beginning in 2025.
Formerly, Dr. Davis was SVP-Research & Development Branded Pharmaceuticals at Endo International Plc, Head-Medical Affairs & Pharmacovigilance at Endo Pharmaceuticals, Inc., Head-Medical Affairs at Dermik Laboratories, Inc., Vice President-Branded Products & Medical Affairs at URL Pharma, Inc., Head-Clinical Development & Medical Affairs at Dr. Reddy's Laboratories, Inc., Chief Medical Officer at Lupin, Inc., and Chief Operating & Medical Officer at Tiziana Life Sciences Ltd. from 2022 to 2024.
Education includes a doctorate from Drexel University College of Medicine and an undergraduate degree from Temple University School of Pharmacy.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 09.03.2026 | 100.000 ( 0,08 % ) | 402 000 $ | 31.05.2026 |
Aktive Positionen von Matthew Davis
| Unternehmen | Position | Beginn |
|---|---|---|
| AQUESTIVE THERAPEUTICS, INC. | Corporate Officer/Principal | 04.11.2025 |
Temple University (Pennsylvania)
 Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Geschäftsführer | - |
Ehemalige bekannte Positionen von Matthew Davis
| Unternehmen | Position | Ende |
|---|---|---|
| TIZIANA LIFE SCIENCES LTD | Geschäftsführer | 01.07.2024 |
Lupin, Inc.
 Lupin, Inc. Pharmaceuticals: MajorHealth Technology Operates a pharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | - |
| ENDO INTERNATIONAL PLC | Corporate Officer/Principal | - |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Corporate Officer/Principal | - |
Dermik Laboratories, Inc.
 Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures health and skin care products | Corporate Officer/Principal | - |
Ausbildung von Matthew Davis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Aquestive Therapeutics, Inc.
 Aquestive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes thin film pharmaceutical and over the counter drug products | Health Technology |
Endo International Plc
 Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Temple University (Pennsylvania)
Temple University (Pennsylvania) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dermik Laboratories, Inc.
Dermik Laboratories, Inc. Household/Personal CareConsumer Non-Durables Manufactures health and skin care products | Consumer Non-Durables |
URL Pharma, Inc.
 URL Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic pharmaceutical products | Health Technology |
Dr. Reddy's Laboratories, Inc.
 Dr. Reddy's Laboratories, Inc. Medical/Nursing ServicesHealth Services Develops pharmaceuticals products | Health Services |
Drexel University College of Medicine
 Drexel University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Temple University School of Pharmacy
 Temple University School of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lupin, Inc.
Lupin, Inc. Pharmaceuticals: MajorHealth Technology Operates a pharmaceutical company | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
